A Simple Binary Supramolecular Co-Assembly Platform for Enhanced Tumor Imaging and Therapy.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery

Background:

• Tumor imaging and therapy face challenges in targeting efficiency, drug delivery, and minimizing off-target effects.
• Existing nanocarriers are often complex to synthesize, expensive, and show limited delivery rates in solid tumors.
• Larger nanocarriers, in particular, struggle with efficient penetration into tumor tissues.

Purpose of the Study:

• To develop a simple, efficient, and adaptable binary co-assembly drug delivery platform for enhanced tumor imaging and therapy.
• To overcome the limitations of existing nanocarriers in terms of synthesis, cost, and tumor penetration.
• To create a system that improves the targeting and retention of imaging probes and therapeutic drugs within tumor cells.

Main Methods:

• Designed a binary co-assembly platform using the small molecule Cys(SEt)-Lys-CBT (CKCBT) as a self-assembly building block.
• Utilized the positively charged Lys side chain and small size of CKCBT for effective tumor cell penetration.
• Achieved co-assembly with Nile red or Chlorin e6 upon glutathione reduction to form tumor cell-specific nanofibers.

Main Results:

• CKCBT demonstrated effective penetration into tumor cells due to its properties.
• Co-assembly with probes/drugs resulted in nanofibers that specifically accumulated within tumor cells.
• Enhanced accumulation and extended exposure time led to precise and improved tumor imaging and treatment outcomes.
• The platform showed adaptability for a broad spectrum of probes and drugs.

Conclusions:

• The developed binary co-assembly platform offers a straightforward and highly effective approach for drug delivery.
• This method significantly improves tumor cell targeting and retention, leading to enhanced imaging and therapeutic outcomes.
• The platform's adaptability makes it a promising novel strategy for advancing clinical diagnosis and therapy.